Medicare Enrolled
Dr. Christian Khoury, MD
Hematology & Oncology · Quincy, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khoury from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khoury?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khoury
Dr. Christian Khoury is a hematology & oncology specialist in Quincy, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khoury performed 79,343 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khoury received a total of $5,924 from 59 pharmaceutical and/or device companies across 355 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khoury is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 14% volume in IL
$5,924 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗79,343
Medicare services
Top 14% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
31,500 | $1 | $4 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,400 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 8,200 | $43 | $124 |
| Denosumab injection (Prolia/Xgeva) | 6,480 | $18 | $54 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
6,000 | $0 | $1 |
| Paclitaxel chemotherapy injection | 4,522 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,036 | $0 | $2 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,640 | $36 | $172 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,110 | $1 | $14 |
| Injection, granisetron hydrochloride, 100 mcg | 850 | $0 | $3 |
| Injection, leucovorin calcium, per 50 mg | 791 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
580 | $92 | $277 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
419 | $2 | $11 |
| Injection, potassium chloride, per 2 meq | 350 | $0 | $2 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
330 | $11 | $77 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
322 | $1 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
313 | $95 | $506 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
276 | $83 | $1,236 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $62 | $189 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
218 | $2 | $14 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
188 | $21 | $117 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
179 | $21 | $122 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
170 | $2 | $6 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
149 | $11 | $65 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
138 | $46 | $234 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
118 | $6 | $78 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
116 | $47 | $245 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
92 | $135 | $385 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
82 | $2 | $18 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
73 | $24 | $183 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
71 | $19 | $110 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
49 | $15 | $76 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
41 | $15 | $73 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
35 | $195 | $615 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
34 | $1 | $16 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
33 | $17 | $90 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
32 | $25 | $109 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
30 | $9 | $58 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $116 | $442 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
26 | $4 | $19 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
26 | $1 | $15 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
21 | $14 | $66 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
20 | $41 | $204 |
| New patient office visit, complex (60-74 min) | 20 | $161 | $552 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
43.0% high complexity
55.6% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,924
Total received (2018-2024)
Avg $846/year across 7 years
Top 39% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
355
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$996
2023
$700
2022
$64
2021
$34
2020
$313
2019
$1,851
2018
$1,967
Payments by company (2024)
Astellas Pharma US Inc
$91
GENZYME CORPORATION
$79
Merck Sharp & Dohme LLC
$70
AstraZeneca Pharmaceuticals LP
$65
PFIZER INC.
$62
Genentech USA, Inc.
$61
Daiichi Sankyo Inc.
$59
Regeneron Healthcare Solutions, Inc.
$55
Gilead Sciences, Inc.
$54
Janssen Biotech, Inc.
$45
Organon Llc
$45
Novartis Pharmaceuticals Corporation
$38
Celgene Corporation
$29
Grifols USA, LLC
$28
SOBI, INC
$26
Tempus AI, Inc
$25
Mirati Therapeutics, Inc.
$25
ABBVIE INC.
$23
Karyopharm Therapeutics Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Myriad Genetic Laboratories, Inc.
$17
Incyte Corporation
$16
Spectrum Pharmaceuticals Inc.
$14
Fennec Pharmaceuticals, Inc.
$14
Top 3 companies account for 24.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$502
AstraZeneca Pharmaceuticals LP
$484
Genentech USA, Inc.
$383
Amgen Inc.
$368
Merck Sharp & Dohme Corporation
$360
E.R. Squibb & Sons, L.L.C.
$330
PFIZER INC.
$324
GENZYME CORPORATION
$313
Janssen Biotech, Inc.
$288
Astellas Pharma US Inc
$186
Celgene Corporation
$180
Daiichi Sankyo Inc.
$145
Janssen Pharmaceuticals, Inc
$121
Exelixis Inc.
$106
Merck Sharp & Dohme LLC
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Lilly USA, LLC
$86
Gilead Sciences, Inc.
$83
JAZZ PHARMACEUTICALS INC.
$82
Regeneron Healthcare Solutions, Inc.
$80
Clovis Oncology, Inc.
$79
Alexion Pharmaceuticals, Inc.
$74
Foundation Medicine, Inc.
$69
Incyte Corporation
$67
Karyopharm Therapeutics Inc.
$62
EMD Serono, Inc.
$61
SANOFI-AVENTIS U.S. LLC
$60
Organon Llc
$45
Pharmacyclics LLC, An AbbVie Company
$44
SOBI, INC
$44
Agios Pharmaceuticals, Inc.
$39
TESARO, Inc.
$38
Puma Biotechnology, Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$36
Taiho Oncology, Inc.
$35
AVEO Pharmaceuticals, Inc.
$35
Lexicon Pharmaceuticals, Inc.
$33
Genmab U.S., Inc.
$32
Eisai Inc.
$32
Rigel Pharmaceuticals, Inc.
$31
Grifols USA, LLC
$28
Takeda Pharmaceuticals U.S.A., Inc.
$28
Tempus AI, Inc
$25
Mirati Therapeutics, Inc.
$25
ABBVIE INC.
$23
AbbVie, Inc.
$19
CTI BioPharma Corp.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Myriad Genetic Laboratories, Inc.
$17
Dova Pharmaceuticals
$17
Ipsen Biopharmaceuticals, Inc
$15
Array BioPharma Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Fennec Pharmaceuticals, Inc.
$14
EISAI INC.
$13
Seattle Genetics, Inc.
$13
Helsinn Therapeutics (U.S.), Inc.
$12
ADC Therapeutics America, Inc.
$11
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Avastin · BOSULIF · Balversa · Bavencio · Braftovi · CABLIVI · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · GIVLAARI · Gamunex-C · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · IRESSA · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONTRUZANT · OPDIVO · OPDUALAG · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Perjeta · Pomalyst · REBLOZYL · ROLVEDON · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SOLIRIS · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
7
County median income
$64,962
Nearest hospital to ZIP centroid (approximate)
BLESSING HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khoury is a mixed practice specialist, with above-average Medicare volume (top 14% in IL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khoury experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Khoury performed 31,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khoury receive payments from pharmaceutical companies?
Yes. Dr. Khoury received a total of $5,924 from 59 companies across 355 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khoury's costs compare to other hematology & oncology specialists in Quincy?
Dr. Khoury's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khoury) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Quincy
Browse hematology & oncology specialists in Quincy ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology